Xpect Naproxen Sodium is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Cintas Corporation. The primary component is Naproxen Sodium.
| Product ID | 42961-209_39ee1ea9-b45b-4137-833d-213a21bc69ce |
| NDC | 42961-209 |
| Product Type | Human Otc Drug |
| Proprietary Name | Xpect Naproxen Sodium |
| Generic Name | Naproxen Sodium |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-03-31 |
| Marketing Category | ANDA / |
| Application Number | ANDA091353 |
| Labeler Name | Cintas Corporation |
| Substance Name | NAPROXEN SODIUM |
| Active Ingredient Strength | 220 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-03-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA091353 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2019-05-17 |
| Marketing Category | ANDA |
| Application Number | ANDA091353 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2019-05-17 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0280-6000 | Aleve | NAPROXEN SODIUM |
| 0280-6010 | Aleve | NAPROXEN SODIUM |
| 0280-6020 | Aleve | NAPROXEN SODIUM |
| 0280-0041 | Aleve Headache Pain | Naproxen Sodium |
| 0113-7033 | basic care naproxen sodium | Naproxen Sodium |
| 0113-7368 | Basic Care Naproxen Sodium | Naproxen Sodium |
| 0113-7901 | basic care naproxen sodium | Naproxen Sodium |
| 0113-0901 | Good Sense Naproxen Sodium | Naproxen Sodium |
| 0113-1412 | good sense naproxen sodium | naproxen sodium |
| 0113-1773 | good sense naproxen sodium | Naproxen Sodium |
| 0113-4368 | Good Sense Naproxen Sodium | Naproxen Sodium |
| 0280-0270 | Menstridol | NAPROXEN SODIUM |
| 0143-9908 | NAPROXEN | naproxen sodium |
| 0143-9916 | NAPROXEN | naproxen sodium |